Inhaled NanoPac® in Treatment of Lung Cancer
FILTERS
TOPICS
NanOlogy to Unveil Positive Preclinical Data for Inhaled NanoPac® in Treatment of Lung Cancer at 2018 ASCO Annual Meeting
Update – 6/4/18: Link to NanOlogy Poster presented at 2018 ASCO Annual Meeting Studies of Inhaled NanoPac Show Prolonged Retention … Continued
More >New Cancer Answer
FORT WORTH, Texas—Researchers have been trying to develop therapeutic agents powerful enough to destroy tumors without harmful effects to healthy … Continued
More >NanOlogy Takes Nanoparticle Tech into Phase II Trials
OCTOBER 16, 2017 BY SARAH FAULKNER In the last two weeks, NanOlogy has launched trials evaluating its cancer-fighting paclitaxel nanoparticle suspension in patients with … Continued
More >DFB Pharmaceuticals, CritiTech, and US Biotest Form NanOlogy™ for Clinical Development of Naked Nanoparticle Platform to Treat Cancer and Related Illnesses
September 12, 2017 05:30 AM Eastern Daylight Time FORT WORTH, Texas–(BUSINESS WIRE)–DFB Pharmaceuticals, a private investment and development group, in … Continued
More >